Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Neuropharmacology. 2014 Jun 2;85:243–252. doi: 10.1016/j.neuropharm.2014.05.033

Figure 3.

Figure 3

Locomotor activity observed during the exposure phase: NAcc mKal7. Data are shown as mean (+SEM) 2-hour total locomotor counts observed following amphetamine (Paired) or saline (Unpaired and Control) injections on each of the 4 exposure days. Amphetamine was administered at a dose of 1.5 mg/kg, IP, on each day. These 4 exposure days coincided with the 4 post-infection days when mKal7 was expressed in the NAcc. Expression of mKal7 produced no detectable effects in this phase. n/group=5-6.